Kerecis raises $21m in loans and convertible notes to fuel expansion
Kerecis, the medical fish skin company, recently announced it had raised $21m from Silicon Valley Bank and previous investors to support the company’s expansion plans in…
Kerecis partners with National Hospital of Iceland to evaluate effectiveness of Kerecis products on COVID-19 patients
Kerecis and the National Hospital of Iceland are conducting a randomized, controlled, double-blind clinical study to evaluate the effectiveness of the Kerecis Omega3 Viruxide system on COVID-19 patients.…